medigraphic.com
ISSN 1561-3127 (Electronic)
ISSN 0864-3466 (Print)

2017, Number 2

<< Back Next >>

Revista Cubana de Salud Pública 2017; 43 (2)

Factors associated to hip fracture in 'Dr Salvador Allende'clinical and surgical hospital

Rego HJJ, Hernández SCA, Andreu FAM, Lima BML, Torres LML, Vázquez MM

Language: Spanish
References: 39
Page: 149-165
PDF size: 231.98 Kb.


ABSTRACT

Introduction: Hip fracture is one of the main causes of hospitalization in the elderly and is associated to several risk factors.
Objective: To determine the factors associated to hip fractures in patients aged over 65 years in "Dr Salvador Allende" hospital.
Methods: A case-control, analytical, observational and epidemiological study was carried out in 2013 in patients with hip fracture. Selected demographic and clinical variables were taken into consideration. Summary statistical methods and odds ratio were used to estimate risk, and the logistic regression to assess the confounding factors.
Results: The study included 196 cases and 392 controls. The variables associated to hip fracture were age OR: 1.9; 95 % CI: 1.3-2.9; p= 0.001); race (OR: 4,2; 95 % CI: 2.3-7.6; p= 0.000); APP of hip fracture (OR: 4.1; IC 95 %: 1.5-11.1; p= 0.005) of falls (OR: 2.2; 95 % CI: 1.1-4.3; p= 0.020); blood hypertension (OR: 2.6; 95 % CI: 1.7-4.1; p= 0.000); present consumption of antihypertensive drugs (OR: 4.4; 95 % CI: 1.5-12.8; p= 0.007), and antiangina drugs (OR: 0.1; 95 % CI: 0.1-0.9; p= 0.027).
Conclusions: Age, race, history of hip fracture, falls, blood hypertension, and present consumption of antihypertensive drugs are the variables statistically associated to increased risk of hip fractures. The consumption of anti-angina drugs acts as protective factor.


REFERENCES

  1. Roca R., Smith V., Paz E., Losada J., Serret B., Toirac E., et al.; Temas de Medicina Interna, Tomo I (cap. 42). Geriatría y gerontología. Una introducción necesaria. 4ta ed. La Habana: Editorial Ciencias Médicas; 2004.

  2. Plan de calidad para el Sistema Nacional de Salud. Indicadores clave del SNS. La Habana: Ministerio de Sanidad y consumo; 2007. Acceso: 27 Ener 2012. Disponible en: http://www.msc.es/estadEstudios/estadisticas/sisInfSanSNS/pdf/nivelNacINCLASN S_ Diciembre2007.pdf

  3. Anuario estadístico de salud. La Habana: Ministerio de salud Pública; 2012. Acceso: 5 Abr 2014. Disponible en: http://www.sld.cu/sitios/dne

  4. Sociedad Española de Geriatría y Gerontología. Guías de actuación clínica. Polifarmacia. Madrid: Sociedad; 2000. Acceso: 6 Mar 2012. Disponible en: http://www.saludaliamedica.com/Med/protocolos/segg/SEGG_polifarmacia/protocol o.htm

  5. Servicio Madrileño de Salud. Utilización de medicamentos en el anciano. Notas Farmacoter. 2008;15(8):29-36.

  6. Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol. 2006;63:177-86.

  7. La Croix A, Beck T, Cauley J, Lewis C, Bassford T, Jackson R, et al. Hip structural geometry and incidence of hip fracture in postmenopausal women: what does it add to conventional bone mineral density? Osteoporos Int. 2010;21:919-29.

  8. Trimpou P, Landin-Wilhelmsen K, Odén A, Rosengren A, Wilhelmsen L. Male risk factors for hip fracture a 30 year follow up study in 7,495 men. Osteoporos Int. 2010;21:409-16.

  9. World Health Organization. Prevention and management of osteoporosis. Report of a WHO Scientific Group. Geneva: WHO; 2003 (WHO Technical Report Series, No. 921).

  10. Alonso González L, Vásquez GM, Molina JF. Epidemiology of osteoporosis. Rev Colomb Reumatol. 2009;16:61-75.

  11. Bliuc D, Nguyen D, Milch V, Nguyen T, Eisman J, Center J. Mortality risk associated with low trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301(5):513-21.

  12. Haentjens P, Lamraski G, Boonen S. Costs and consequences of hip fracture occurrence in old age: an economic perspective. Disabil Rehabil. 2005;27:1129-41.

  13. Jha R, Mithal A, Malhotra N, Brown E. Pilot case-control investigation of risk factors for hip fractures in the urban Indian population. BMC Musculo skeletal Dis. 2010;11:49.

  14. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7:407-13.

  15. Cooper C, Campion G, Melton LJ III. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285-9.

  16. Johnell O. The socioeconomic burden of fractures: today and in the 21st century. Am J Med. 1997;103:20S-5S.

  17. Dubey A, Koval KJ, Zuckerman JD. Hip fracture epidemiology: a review. Am J Orthop. 1999;28:497-506.

  18. Benetos IS, Babis GC, Zoubos AB, Benetou V, Soucacos PN. Factors affecting the risk of hip fractures. Injury. 2007;38:735-44.

  19. Wehren LE, Magaziner J. Hip fracture: risk factors and outcomes. Curr Osteoporos Rep. 2003;1:78-85.

  20. Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T, Fiore CE. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporosis Int. 2004;15:389-95.

  21. Sennerby U, Farahmand B, Ahlbom A, Ljunghall S, Michaëlsson K. Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int. 2007;18:1355-62.

  22. Murgadas Rodríguez R. Lesiones traumáticas de la cadera. En: Álvarez Cambras R, Ceballos Mesa A, Murgadas Rodríguez R, editores. Tratado de cirugía ortopédica y traumatológica. T.1. La Habana: Editorial Pueblo y Educación; 1985. p. 313-29.

  23. Johansson H, Kanis JA, Johnell O, McCloskey E. BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int. 2009;20:1675-82.

  24. Lan TY, Hou M, Chen Y, Chang C, Lin J, Lin C, Liu J, Shih F, Tai Y. Risk factors for hip fracture in older adults: a case-control study in Taiwan. Osteoporos Int. 2010;21:773-84.

  25. Franklin J, Englund M, Ingvarsson T, Lohmander S. The association between hip fracture and hip osteoarthritis: A case-control study. BMC Musculo skeletal Dis. 2010;11:274.

  26. Orces CH. Trends in hip fracture rates in Ecuador and projections for the future. Rev Panam Salud Pública. 2011;29(1):27-31.

  27. Sennerby U, Farahmand A, Ahlbom S, Ljunghall K. Michaëlsson. Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int. 2007;18:1355-62.

  28. Kanis JA; on be'haf of the WHO Scientific Group. Assessment of Osteoporosis at the Primary Health Care Level. Geneva: WHO; 2008.

  29. Da Silva ZA, Gómez A. Morbilidad, factores de riesgo y consecuencias de las caídas en ancianos. Fisioterapia. 2008;30(3):142-51.

  30. Varas-Fabra F, Castro E, Pérula LA, Fernández MJ, Ruiz R, Enciso I. Caídas en ancianos de la comunidad: prevalencia, consecuencias y factores asociados. Aten Primaria. 2006;38(8):450-5.

  31. Kragh A, Elmsta I, Atroshi I. Older Adults' Medication Use 6 Months Before and After Hip Fracture: A Population-Based Cohort Study. J Am Geriatr Soc. 2011;59:863-8.

  32. Marín JM, López JA. Las caídas en el anciano desde el punto de vista médico. Rev Sociedad Andaluza Geriatría Gerontología. 2004;2(3):3-10.

  33. Wu Q, Liu J, Gallegos-Orozco JF, Hentz JG. Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int. 2010;21(10):1627-35.

  34. Oderda LH, Young JR, Asche CV, Pepper GA. Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs. Ann Pharmacother. 2012;46(7-8):917-28.

  35. Yang S, Nguyen N, Center J, Eisman J, Nguyen T. Association between betablocker use and fracture risk: The Dubbo Osteoporosis Epidemiology Study. Bone. 2011;48:451-5.

  36. Yang S, Nguyen N, Eisman J, Nguyen T. Association between beta-blockers and fracture risk: A Bayesian meta-analysis. Bone. 2012;51:969-74.

  37. Hong Ji Song. β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients. Bone. 2012; 51:1008-15.

  38. Juliebo V, Krogseth M, Skovlund E, Engedal K, Wyller TB. Medical treatment predicts mortality after hip fracture. J Gerontol A Biol Sci Med Sci. 2010;65:442-9.

  39. Carbonel L, Buzkova P, Fink HA. Hip fractures and heart failure: findings from the Cardiovascular Health Study. Eur Heart J. 2010;31:77-84.




2020     |     www.medigraphic.com